Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden

Cancer Immunology Immunotherapy(2021)10.1007/s00262-020-02837-9Source: DataRank Database

Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden is a research paper published in Cancer Immunology Immunotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: hybridTopics (58)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Rui Li ORCID,Linh M. Tran ORCID,Raymond J. Lim ORCID,Jensen Abascal ORCID,Milica Momcilovic ORCID

Live enrichment

PubMed:33507343 PMC:PMC8289771

National Cancer Institute

Grant: 1U01-CA196408

National Heart Lung and Blood Institute

Grant: T32-HL072752

National Center for Advancing Translational Sciences

Grant: UL1TR001881

NCI NIH HHS

Grant: P30 CA016042

NCI NIH HHS

Grant: R01 CA208642

NCI NIH HHS

Grant: T32 CA009120

NCI NIH HHS

Grant: U01 CA196408

NHLBI NIH HHS

Grant: T32 HL072752

National Institutes of Health

Grant: 5T32HL072752-07

Pulmonary and Critical Care Medicine Training Program

National Institutes of Health

Grant: 5P30AI028697-26

Biostatistics Core

National Institutes of Health

Grant: 3UL1TR001881-01S2

UCLA Clinical Translational Science Institute

National Institutes of Health

Grant: 5U01CA196408-03

Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer

Fundação para a Ciência e a Tecnologia, I.P.

Grant: Incentivo/SAU/LA0001/2013

Incentive - LA 1 - 2013

National Institutes of Health

Grant: 3P30CA016042-35S3

Cancer Center Support Grant

U.S. Department of Veterans Affairs

hybridLicense: cc-by

HYBRIDhttps://link.springer.com/content/pdf/10.1007/s00262-020-02837-9.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-020-02837-9.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-020-02837-9/fulltext.html

repositoryhttps://escholarship.org/uc/item/0nb5s9nd

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8289771

Fields of Study

BiologyMedicine0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Cell Line, TumorAnimalsMiceCarcinoma, Non-Small-Cell LungLung NeoplasmsDisease Models, AnimalMutationTumor Suppressor Protein p53Proto-Oncogene Proteins p21(ras)Tumor MicroenvironmentBiomarkers, TumorB7-H1 AntigenProtein Serine-Threonine Kinases

Keywords

TMBImmunotherapyNSCLCKrasLkb1Mouse Cancer ModelsResearch ReportLung NeoplasmsOncology and CarcinogenesisImmunology610Protein Serine-Threonine KinasesB7-H1 AntigenCell LineProto-Oncogene Proteins p21(ras)MiceCarcinoma, Non-Small-Cell LungCell Line, TumorGeneticsBiomarkers, TumorTumor Microenvironment2.1 Biological and endogenous factorsAnimalsNon-Small-Cell LungLungCancerTumorBiomedical and Clinical SciencesAnimalLung CancerCarcinomaDisease Models, AnimalGood Health and Well Being5.1 PharmaceuticalsDisease ModelsMutationWomen's HealthTumor Suppressor Protein p53BiomarkersBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health